Drug Profile
MetXia gene therapy - Oxford BioMedica
Alternative Names: MetXia; MetXia-MG; MetXia-P450; MetXia-VM; P450-GDEPTLatest Information Update: 18 Sep 2015
Price :
$50
*
At a glance
- Originator Oxford BioMedica
- Class Gene therapies
- Mechanism of Action Cytochrome P-450 enzyme system modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Suspended Pancreatic cancer
- Discontinued Breast cancer; Malignant melanoma; Ovarian cancer